Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro mode...
Published in American Journal of Psychiatry
Published in American Journal of Psychiatry
Published in American Journal of Psychiatry
Published in American Journal of Psychiatry
Published in The American journal of psychiatry
In 2005-2006, several studies noted an increased risk of cardiovascular birth defects associated with maternal use of paroxetine compared with other antidepressants in the same class. In this study, the authors sought to determine whether paroxetine was associated with an increased risk of cardiovascular defects in infants of women exposed to the d...
Published in The American journal of psychiatry
An important current hypothesis suggests that the relationship between severe depression and the hippocampus is essentially toxic. The purpose of this study was to assess the generalizability of the impact of depression on hippocampal function. Participants were 8,229 outpatients who 1) fulfilled DSM-IV criteria for major depressive disorder based ...
Published in American Journal of Psychiatry
Published in American Journal of Psychiatry
Thirty-one hyperactive adolescents treated with methylphenidate for at least 6 months demonstrated no significant deviation from expected height and weight growth velocities. In contrast to findings in prepubertal children, these results suggest that early adolescent growth is insensitive to methylphenidate.
Published in American Journal of Psychiatry
Published in American Journal of Psychiatry
Three depressed geriatric patients had a marked therapeutic response to the psychostimulant drug methylphenidate. These patients either had been unable to tolerate tricyclic antidepressants or had a medical illness that contraindicated tricyclic therapy. The lack of adverse effects in our elderly patients and methylphenidate's effectiveness as an a...
Published in American Journal of Psychiatry